Pancreatic Cancer Research

ResearcherUniversity of KentuckyActive in the last 2 years

Anna M. Reagan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-7109-8342; OpenAlex author ID A5114178343. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Case Report: Prolonged response to cabozantinib and pembrolizumab in treatment-refractory metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2026.1675133↗
  2. Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer. First author DOI 10.1002/1878-0261.70062↗
  3. Development of a Novel Protocol for Germline Testing in Pancreatic Cancer. Co-author DOI 10.1245/s10434-024-16011-3↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hannah G. McDonald · 3 shared papers, 2024–2026 · strength 0.61
  2. Michael J. Cavnar · 3 shared papers, 2024–2026 · strength 0.61
  3. Joseph Kim · 3 shared papers, 2024–2026 · strength 0.61
  4. Reema Anil Patel · 2 shared papers, 2024–2026 · strength 0.41
  5. Megan M. Harper · 2 shared papers, 2024–2025 · strength 0.36
  6. Mei Gao · 1 shared paper, 2025 · strength 0.20
  7. Emily Cassim · 1 shared paper, 2024 · strength 0.16
  8. Erin E. Burke · 1 shared paper, 2024 · strength 0.16
  9. Chelsey Mckenna Williams · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.